Pubblicazioni per linea Myriapod

21 07, 2020

Umberto Malapelle et. al., Predictive molecular pathology in the time of coronavirus disease

Diatech Pharmacogenetics 2020-11-03T14:14:46+00:00

Leggi di più

29 06, 2020

Marco Mammana et. al., Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis

Diatech Pharmacogenetics 2020-11-03T14:34:16+00:00

Leggi di più

16 05, 2020

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Diatech Pharmacogenetics 2020-11-03T15:11:21+00:00

Leggi di più

7 05, 2020

Elisabetta Zulato et. al., Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

Diatech Pharmacogenetics 2020-11-03T15:24:44+00:00

Leggi di più

31 07, 2019

Sergio Migliore et al., Large-scale PRNP genotyping of small ruminants using an automated high-throughput MALDI-TOF MS assay.

Marco Amadio 2020-01-22T12:17:44+00:00

Leggi di più

2 05, 2019

Paola Bordi et al., From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

Marco Amadio 2020-01-22T12:42:02+00:00

Leggi di più

29 04, 2019

Michela Notarangelo et al., Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood

Marco Amadio 2020-01-22T12:22:34+00:00

Leggi di più

11 04, 2019

Enrico Mini et al., RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

Marco Amadio 2020-01-22T12:23:58+00:00

Leggi di più

14 02, 2019

Lorenza Rimassa et al., Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition

Marco Amadio 2020-01-22T12:34:31+00:00

Leggi di più

15 11, 2018

Matteo Fassan et. al, miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

Diatech Pharmacogenetics 2018-12-04T14:44:48+00:00

Leggi di più